These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2050167)

  • 21. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the diuretic response to oral and intravenous furosemide in "duretic-resistant" patients.
    Kelly MR; Blair AD; Forrey AW; Smidt NA; Cutler RE
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):1-9. PubMed ID: 401702
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination of long-acting furosemide and instant-acting amiloride: pharmacokinetics and pharmacodynamics in human subjects.
    Flouvat B; Roux A; Leneveu A; Prinseau J; Alexandre JA
    Fundam Clin Pharmacol; 1991; 5(8):741-52. PubMed ID: 1783363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.
    Alván G; Paintaud G; Eckernäs SA; Grahnén A
    Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs.
    Koh SK; Jeong JW; Choi SI; Kim RM; Koo TS; Cho KH; Seo KW
    BMC Vet Res; 2021 Sep; 17(1):295. PubMed ID: 34488750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.
    Yagi N; Kiuchi T; Satoh H; Terashima Y; Kenmotsu H; Sekikawa H; Takada M
    Biol Pharm Bull; 1996 Apr; 19(4):616-22. PubMed ID: 8860970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers.
    van Meyel JJ; Smits P; Russel FG; Gerlag PG; Tan Y; Gribnau FW
    Clin Pharmacol Ther; 1992 Apr; 51(4):440-4. PubMed ID: 1563213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of cyclophosphamide-induced antidiuresis by furosemide infusion.
    Green TP; Mirkin BL
    Clin Pharmacol Ther; 1981 May; 29(5):634-42. PubMed ID: 7214794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients.
    Inoue M; Okajima K; Itoh K; Ando Y; Watanabe N; Yasaka T; Nagase S; Morino Y
    Kidney Int; 1987 Aug; 32(2):198-203. PubMed ID: 3656933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased diuretic response to furosemide in rats with glycerol-induced acute renal failure.
    Kamiya A; Hayashi Y; Kikkoji T; Huang Y; Inui K; Hori R
    J Pharmacobiodyn; 1988 Aug; 11(8):541-8. PubMed ID: 3236211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans.
    Vree TB; van der Ven AJ
    J Pharm Pharmacol; 1999 Mar; 51(3):239-48. PubMed ID: 10344623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms.
    Oztürk B; Cetinkaya M; Oztekin V; Inal G; Adsan O; Uğurlu O; Ozden C
    Urol Int; 2003; 71(1):22-5. PubMed ID: 12845255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption and disposition of furosemide in congestive heart failure.
    Brater DC; Seiwell R; Anderson S; Burdette A; Dehmer GJ; Chennavasin P
    Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
    Hammarlund MM; Odlind B; Paalzow LK
    J Pharmacol Exp Ther; 1985 May; 233(2):447-53. PubMed ID: 3999028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based meta-analysis of furosemide pharmacokinetics.
    Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
    Biopharm Drug Dispos; 2014 Mar; 35(2):119-33. PubMed ID: 24151207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.
    Wakelkamp M; Alván G; Gabrielsson J; Paintaud G
    Clin Pharmacol Ther; 1996 Jul; 60(1):75-88. PubMed ID: 8689815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloxacillin absorption and disposition in cystic fibrosis.
    Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
    J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.